Nikolay V. Pervushin

Cancer Drug Resistance: Targeting Proliferation or Programmed Cell Death

Elena V. Sazonova, Maria A. Yapryntseva, Nikolay V. Pervushin et al. · Cells · 2024 · 26 citations · Full text

Oncology, Cancer Drug Resistance, Medicine +12

2,4,5-Tris(alkoxyaryl)imidazoline derivatives as potent scaffold for novel p53-MDM2 interaction inhibitors: Design, synthesis, and biological evaluation

Daniil R. Bazanov, Nikolay V. Pervushin, Viktoriia Yu. Savitskaya et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 25 citations

Combinatorial Chemistry, Medicinal Chemistry, Biochemistry +9

Synthetic Design and Biological Evaluation of New p53-MDM2 Interaction Inhibitors Based on Imidazoline Core

Daniil R. Bazanov, Nikolay V. Pervushin, Egor V. Savin et al. · Pharmaceuticals · 2022 · 19 citations · Full text

Sulfonamide derivatives of cis-imidazolines as potent p53-MDM2/MDMX protein-protein interaction inhibitors

Daniil R. Bazanov, Nikolay V. Pervushin, Egor V. Savin et al. · Medicinal Chemistry Research · 2021 · 17 citations

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +11

Optical Monitoring of the Biodegradation of Porous and Solid Silicon Nanoparticles

M. B. Gongalsky, Nikolay V. Pervushin, Daria E. Maksutova et al. · Nanomaterials · 2021 · 14 citations · Full text